HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

Aprotinin overview
Aprotonin is a haemostatic. High doses offer major reductions in perioperative blood loss and the need for donor blood transfusions. It is indicated for the treatment of: patients with life threatening haemorrhage due to hyperplasminaemia; patients considered to be at high risk of major blood loss associated with open heart surgery with extracorporeal circulation; patients in whom blood transfusion is not an option so that optimal blood conservation during open heart surgery is an absolute priority (eg, Jehovah's witnesses).
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
Aprotinin
Drug Class Description :

Haemostatics (polyvalent protease inhibitors).

Generic Name :

Generic

Drug description :

Injection.

Presentation :

Injection, aprotinin 10,000 KIU/ mL.

Indications :

Aprotonin is a haemostatic. High doses offer major reductions in perioperative blood loss and the need for donor blood transfusions. It is indicated for the treatment of: patients with life threatening haemorrhage due to hyperplasminaemia; patients considered to be at high risk of major blood loss associated with open heart surgery with extracorporeal circulation; patients in whom blood transfusion is not an option so that optimal blood conservation during open heart surgery is an absolute priority (eg, Jehovah's witnesses).

Adult Dosage :

To be given by slow intravenous injection or infusion. Hyperplasminaemia: 500,000 to 1, 000,000 KIU (277.8 - 555.6 Ph. Eur. units) (maximum rate 10mL/ minute) followed by 200,000 KIU minute) followed by 200,000 KIU (111.1 Ph. Eur. units) hourly if necessary, until bleeding stops.

Child Dosage :

Hyperplasminaemia: It is recommended that a dose proportional to the adult dose, based on body weight, is calculated. Open heart surgery: Dosage has not been established.

Elderly Dosage :

Hyperplasminaemia: The dosage above relates to persons of average body weight. Reductions of these doses should be considered in patients of below average weight. Open heart surgery: Refer to Summary of Product Characteristics.

Contra Indications :

Known hypersensitivity to aprotinin.

Special Precautions :

Avoid rapid intravenous injection of large doses. Caution in patients treated intermittently or patients treated previously with aprotinin; discontinue treatment if hypersensitivity reactions are observed. Adding aprotinin to heparinised blood prolongs activated clotting time. Pregnancy and lactation.

Interactions :

None stated.

Adverse Reactions :

Local thrombophlebitis, nausea and vomiting, diarrhoea, muscle pains, blood pressure changes. Allergic reactions such as erythema, urticaria and bronchospasm have occurred occasionally. Also, anaphylaxis, tachycardia, pallor or cyanosis, dyspnoea. Reddening of skin on repeated dosage.

Manufacturer :

Ferring

Drug Availability :

(POM)

Drug Updated :

04 June 2009

Related Drugs - Haemostatics
Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Atopic Dermatitis- understanding, management, diagnosis and treatment information Lysosomal storage disorders (LSDs) are a group of progressive and often fatal genetic diseases that are caused by an inborn error of metabolism
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES